Medical - Distribution
Compare Stocks
5 / 10Stock Comparison
MCK vs AMZN vs ORCL vs MSFT vs CRM
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
Software - Infrastructure
Software - Infrastructure
Software - Application
MCK vs AMZN vs ORCL vs MSFT vs CRM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Distribution | Specialty Retail | Software - Infrastructure | Software - Infrastructure | Software - Application |
| Market Cap | $92.15B | $2.92T | $559.27B | $3.13T | $179.19B |
| Revenue (TTM) | $403.43B | $742.78B | $64.08B | $318.27B | $41.52B |
| Net Income (TTM) | $4.76B | $90.80B | $16.21B | $125.22B | $7.46B |
| Gross Margin | 3.6% | 50.6% | 66.4% | 68.3% | 77.7% |
| Operating Margin | 1.5% | 11.5% | 30.8% | 46.8% | 21.5% |
| Forward P/E | 19.3x | 34.8x | 26.0x | 25.3x | 15.8x |
| Total Debt | $7.39B | $152.99B | $104.10B | $112.18B | $6.74B |
| Cash & Equiv. | $5.69B | $86.81B | $10.79B | $30.24B | $7.33B |
MCK vs AMZN vs ORCL vs MSFT vs CRM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| McKesson Corporation (MCK) | 100 | 474.1 | +374.1% |
| Amazon.com, Inc. (AMZN) | 100 | 222.1 | +122.1% |
| Oracle Corporation (ORCL) | 100 | 361.8 | +261.8% |
| Microsoft Corporati… (MSFT) | 100 | 229.7 | +129.7% |
| Salesforce, Inc. (CRM) | 100 | 106.6 | +6.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MCK vs AMZN vs ORCL vs MSFT vs CRM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MCK has the current edge in this matchup, primarily because of its strength in valuation efficiency.
- PEG 0.49 vs ORCL's 3.66
- 16.2% revenue growth vs ORCL's 8.4%
- Beta 0.04 vs ORCL's 1.59
AMZN is the clearest fit if your priority is growth exposure.
- Rev growth 12.4%, EPS growth 29.7%, 3Y rev CAGR 11.7%
- +43.7% vs CRM's -32.4%
Among these 5 stocks, ORCL doesn't own a clear edge in any measured category.
MSFT is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 7.9% 10Y total return vs ORCL's 425.1%
- 39.3% margin vs MCK's 1.2%
- 19.2% ROA vs MCK's 5.7%, ROIC 24.9% vs 5.4%
CRM ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.82, yield 0.9%
- Lower volatility, beta 0.82, Low D/E 11.4%, current ratio 0.76x
- Beta 0.82, yield 0.9%, current ratio 0.76x
- Lower P/E (15.8x vs 25.3x), PEG 1.29 vs 1.35
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.2% revenue growth vs ORCL's 8.4% | |
| Value | Lower P/E (15.8x vs 25.3x), PEG 1.29 vs 1.35 | |
| Quality / Margins | 39.3% margin vs MCK's 1.2% | |
| Stability / Safety | Beta 0.04 vs ORCL's 1.59 | |
| Dividends | 0.9% yield, 2-year raise streak, vs MSFT's 0.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +43.7% vs CRM's -32.4% | |
| Efficiency (ROA) | 19.2% ROA vs MCK's 5.7%, ROIC 24.9% vs 5.4% |
MCK vs AMZN vs ORCL vs MSFT vs CRM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MCK vs AMZN vs ORCL vs MSFT vs CRM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CRM leads in 2 of 6 categories
AMZN leads 1 • MCK leads 0 • ORCL leads 0 • MSFT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MSFT and CRM each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 17.9x CRM's $41.5B. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to MCK's 1.2%. On growth, ORCL holds the edge at +21.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $403.4B | $742.8B | $64.1B | $318.3B | $41.5B |
| EBITDAEarnings before interest/tax | $6.8B | $155.9B | $26.5B | $192.6B | $11.4B |
| Net IncomeAfter-tax profit | $4.8B | $90.8B | $16.2B | $125.2B | $7.5B |
| Free Cash FlowCash after capex | $6.0B | -$2.5B | -$24.7B | $72.9B | $14.4B |
| Gross MarginGross profit ÷ Revenue | +3.6% | +50.6% | +66.4% | +68.3% | +77.7% |
| Operating MarginEBIT ÷ Revenue | +1.5% | +11.5% | +30.8% | +46.8% | +21.5% |
| Net MarginNet income ÷ Revenue | +1.2% | +12.2% | +25.3% | +39.3% | +18.0% |
| FCF MarginFCF ÷ Revenue | +1.5% | -0.3% | -38.6% | +22.9% | +34.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.0% | +16.6% | +21.7% | +18.3% | +12.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +37.0% | +74.8% | +24.5% | +23.4% | +18.3% |
Valuation Metrics
CRM leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 23.9x trailing earnings, CRM trades at a 47% valuation discount to ORCL's 44.8x P/E. Adjusting for growth (PEG ratio), MCK offers better value at 0.75x vs ORCL's 6.31x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $92.1B | $2.92T | $559.3B | $3.13T | $179.2B |
| Enterprise ValueMkt cap + debt − cash | $93.8B | $2.98T | $652.6B | $3.21T | $178.6B |
| Trailing P/EPrice ÷ TTM EPS | 29.25x | 37.82x | 44.82x | 30.86x | 23.88x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.28x | 34.77x | 25.99x | 25.34x | 15.82x |
| PEG RatioP/E ÷ EPS growth rate | 0.75x | 1.35x | 6.31x | 1.64x | 1.95x |
| EV / EBITDAEnterprise value multiple | 18.74x | 20.47x | 27.36x | 19.72x | 20.03x |
| Price / SalesMarket cap ÷ Revenue | 0.26x | 4.07x | 9.74x | 11.10x | 4.32x |
| Price / BookPrice ÷ Book value/share | — | 7.14x | 26.59x | 9.15x | 3.01x |
| Price / FCFMarket cap ÷ FCF | 17.63x | 378.98x | — | 43.66x | 12.44x |
Profitability & Efficiency
CRM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $13 for CRM. CRM carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to ORCL's 4.96x. On the Piotroski fundamental quality scale (0–9), CRM scores 8/9 vs MSFT's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.0% | +23.3% | +56.3% | +33.1% | +12.6% |
| ROA (TTM)Return on assets | +5.7% | +11.5% | +8.1% | +19.2% | +6.6% |
| ROICReturn on invested capital | +5.4% | +14.7% | +12.8% | +24.9% | +10.9% |
| ROCEReturn on capital employed | +30.5% | +15.3% | +14.4% | +29.7% | +11.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 6 | 8 |
| Debt / EquityFinancial leverage | — | 0.37x | 4.96x | 0.33x | 0.11x |
| Net DebtTotal debt minus cash | $1.7B | $66.2B | $93.3B | $81.9B | -$590M |
| Cash & Equiv.Liquid assets | $5.7B | $86.8B | $10.8B | $30.2B | $7.3B |
| Total DebtShort + long-term debt | $7.4B | $153.0B | $104.1B | $112.2B | $6.7B |
| Interest CoverageEBIT ÷ Interest expense | 33.79x | 39.96x | 5.44x | 55.65x | 44.14x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $8,775 for CRM. Over the past 12 months, AMZN leads with a +43.7% total return vs CRM's -32.4%. The 3-year compound annual growth rate (CAGR) favors AMZN at 36.8% vs CRM's -1.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -8.5% | +19.7% | -0.1% | -10.8% | -26.4% |
| 1-Year ReturnPast 12 months | +4.6% | +43.7% | +31.6% | -2.1% | -32.4% |
| 3-Year ReturnCumulative with dividends | +106.4% | +156.2% | +106.5% | +39.5% | -4.0% |
| 5-Year ReturnCumulative with dividends | +286.9% | +64.8% | +151.8% | +72.5% | -12.3% |
| 10-Year ReturnCumulative with dividends | +348.1% | +697.8% | +425.1% | +787.7% | +154.6% |
| CAGR (3Y)Annualised 3-year return | +27.3% | +36.8% | +27.3% | +11.7% | -1.4% |
Risk & Volatility
Evenly matched — MCK and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MCK is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than ORCL's 1.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs ORCL's 56.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.04x | 1.51x | 1.59x | 0.89x | 0.82x |
| 52-Week HighHighest price in past year | $999.00 | $278.56 | $345.72 | $555.45 | $296.05 |
| 52-Week LowLowest price in past year | $637.00 | $185.01 | $134.57 | $356.28 | $163.52 |
| % of 52W HighCurrent price vs 52-week peak | +75.3% | +97.3% | +56.3% | +75.8% | +62.9% |
| RSI (14)Momentum oscillator 0–100 | 16.2 | 81.1 | 68.5 | 54.0 | 48.3 |
| Avg Volume (50D)Average daily shares traded | 757K | 45.5M | 26.3M | 32.5M | 12.4M |
Analyst Outlook
Evenly matched — MSFT and CRM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MCK as "Buy", AMZN as "Buy", ORCL as "Buy", MSFT as "Buy", CRM as "Buy". Consensus price targets imply 54.1% upside for CRM (target: $287) vs 13.1% for AMZN (target: $307). For income investors, CRM offers the higher dividend yield at 0.89% vs MCK's 0.36%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $1006.50 | $306.77 | $257.19 | $551.75 | $287.00 |
| # AnalystsCovering analysts | 31 | 94 | 86 | 81 | 97 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | — | +0.9% | +0.8% | +0.9% |
| Dividend StreakConsecutive years of raises | 17 | — | 18 | 19 | 2 |
| Dividend / ShareAnnual DPS | $2.69 | — | $1.65 | $3.23 | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | 0.0% | +0.3% | +0.6% | +7.0% |
CRM leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). AMZN leads in 1 (Total Returns). 3 tied.
MCK vs AMZN vs ORCL vs MSFT vs CRM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MCK or AMZN or ORCL or MSFT or CRM a better buy right now?
For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.
2% revenue growth year-over-year, versus 8. 4% for Oracle Corporation (ORCL). Salesforce, Inc. (CRM) offers the better valuation at 23. 9x trailing P/E (15. 8x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MCK or AMZN or ORCL or MSFT or CRM?
On trailing P/E, Salesforce, Inc.
(CRM) is the cheapest at 23. 9x versus Oracle Corporation at 44. 8x. On forward P/E, Salesforce, Inc. is actually cheaper at 15. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: McKesson Corporation wins at 0. 49x versus Oracle Corporation's 3. 66x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MCK or AMZN or ORCL or MSFT or CRM?
Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.
9%, compared to -12. 3% for Salesforce, Inc. (CRM). Over 10 years, the gap is even starker: MSFT returned +787. 7% versus CRM's +154. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MCK or AMZN or ORCL or MSFT or CRM?
By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.
04β versus Oracle Corporation's 1. 59β — meaning ORCL is approximately 3582% more volatile than MCK relative to the S&P 500. On balance sheet safety, Salesforce, Inc. (CRM) carries a lower debt/equity ratio of 11% versus 5% for Oracle Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — MCK or AMZN or ORCL or MSFT or CRM?
By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.
2% versus 8. 4% for Oracle Corporation (ORCL). On earnings-per-share growth, the picture is similar: Amazon. com, Inc. grew EPS 29. 7% year-over-year, compared to 14. 9% for McKesson Corporation. Over a 3-year CAGR, MSFT leads at 12. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MCK or AMZN or ORCL or MSFT or CRM?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus 0. 9% for McKesson Corporation — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus 1. 2% for MCK. At the gross margin level — before operating expenses — CRM leads at 77. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MCK or AMZN or ORCL or MSFT or CRM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, McKesson Corporation (MCK) is the more undervalued stock at a PEG of 0. 49x versus Oracle Corporation's 3. 66x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Salesforce, Inc. (CRM) trades at 15. 8x forward P/E versus 34. 8x for Amazon. com, Inc. — 19. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRM: 54. 1% to $287. 00.
08Which pays a better dividend — MCK or AMZN or ORCL or MSFT or CRM?
In this comparison, CRM (0.
9% yield), ORCL (0. 9% yield), MSFT (0. 8% yield), MCK (0. 4% yield) pay a dividend. AMZN does not pay a meaningful dividend and should not be held primarily for income.
09Is MCK or AMZN or ORCL or MSFT or CRM better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
89), 0. 8% yield, +787. 7% 10Y return). Amazon. com, Inc. (AMZN) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +787. 7%, AMZN: +697. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MCK and AMZN and ORCL and MSFT and CRM?
These companies operate in different sectors (MCK (Healthcare) and AMZN (Consumer Cyclical) and ORCL (Technology) and MSFT (Technology) and CRM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MCK is a mid-cap high-growth stock; AMZN is a mega-cap quality compounder stock; ORCL is a large-cap quality compounder stock; MSFT is a mega-cap quality compounder stock; CRM is a mid-cap quality compounder stock. ORCL, MSFT, CRM pay a dividend while MCK, AMZN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.